files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346

References

  1. Hegarty, N.J., J.M. Fitzpatrick, J.P. Richie, P.T. Scardino, R.W. deVere White, F.H. Schr�der and D.S. Coffey, 1999. Future prospects in prostate cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Prostate, 40: 1-10.
  2. Chia S.E., W.K. Lau, C. Cheng, C.M. Chin, J. Tan and S.K. Ho., 2007. Prostate-specific antigen levels among Chinese, Malays and Indians in Singapore from a community-based study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Asian Pac J Cancer Prev 8: 1-10.
  3. Choi, H., J. Park, B. Cho, K. Son, Y. Yoo and H. Kwon, 2011. The illusion of prostate‐specific antigen decline in patients with metabolic syndrome and insulin resistance. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, BJU Int., 108: 1-10.
  4. Naito M., Y. Asai, A. Mori, Y. Fukada, M. Kuwabara and S. Katase, et al., 2012. Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Nagoya J Med Sci., 74: 1-10.
  5. Qu, X., Z. Huang, X. Meng, X. Zhang, L. Dong and X. Zhao, 2014. Prostate volume correlates with diabetes in elderly benign prostatic hyperplAsia patients. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. Urol. Nephrology, 46: 1-10.
  6. Benson, M.C., I.S. Whang, A. Pantuck, K. Ring, S.A. Kaplan, C.A. Olsson and W.H. Cooner, 1992. Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Urol., 147: 1-10.
  7. Gordon‐Larsen, P., H. Wang and B.M. Popkin, 2014. Overweight dynamics in CHinese children and adults. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Obesity Rev., 15: 1-10.
  8. Zhang, J., M. Ma, X. Nan and B. Sheng, 2016. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Braz. J. Med. Bio. Res., Vol. 49. 10.1590/1414-431x20165272 1-10.
  9. Abd D.Z. and D.R. Saeed., 2020.  Effects of Obesity On The Serum Levels Of Free And Total Prostate-Specific Antigen In A Sample Of Iraqi Men. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, European Journal of Molecular & Clinical Medicine., 7: 1-10.
  10. Fowke, J.H. and C.E. Matthews, 2010. PSA and body composition by dual X‐Ray absorptiometry (DXA) in NHANES. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Prostate, 70: 1-10.
  11. Skolarus, T.A., K.Y. Wolin and R.L. Grubb, 2007. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Nat. Clin. Pract. Urol., 4: 1-10.
  12. Castro-Fernández, C., A. Olivares, D. Söderlund, J.C. López-Alvarenga and E. Zambrano et al., 2000. A Preponderance of Circulating Basic Isoforms Is Associated with Decreased Plasma Half-Life and Biological to Immunological Ratio of Gonadotropin-Releasing Hormone-Releasable Luteinizing Hormone in Obese Men1. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The J. Clin. Endocrinol. & Metab., 85: 1-10.